Newsmeme!
Discover News you didn't know existed
An analysis of genetic and clinical data for nearly 800 patients with non-small cell lung cancer has identified differences in genetic characteristics that are associated with age and sex specific patterns of increased or decreased recurrence-free survival, according to a study in the February 10 issue of JAMA.
Autism Speaks, the world's largest autism science and advocacy organization has released its annual list of the 10 most significant research achievements to have impacted autism during the previous year. Every year, Autism Speaks documents the progress made toward its mission to discover the causes and treatment for autism spectrum disorders, and compiles a list of the 10 most significant ...
Leading Autism Advocacy Organization Documents Progress to Discover Causes and Treatments for Autism Spectrum DisordersAutism Speaks, the world's largest autism science and advocacy organization, has released its annual list of the 10 most significant research achievements to have impacted autism during the previous year. Every year, Autism Speaks documents the progress made toward its mission ...
( Autism Speaks ) Autism Speaks, the world's largest autism science and advocacy organization has released its annual list of the 10 most significant research achievements to have impacted autism during the previous year, documenting progress towards the discovery of the causes and treatment for autism spectrum disorders. In 2009 clinical and epidemiological research together with advances in ...
YANTAI, China----Bohai Pharmaceuticals Group, Inc. today announced that the company’s ticker symbol as quoted on the OTC Bulletin Board has been changed from OTCBB:LNKR to OTCBB:BOPH effective today, February 9, 2010.
SAN DIEGO----Ligand Pharmaceuticals Incorporated today announced financial results for the three and 12 months ended December 31, 2009, and reviewed business highlights of the fourth quarter of 2009 and early 2010.
DUBLIN----Research and Markets has announced the addition of Frost & Sullivan's new report "Rheumatoid Arthritis Therapeutics Market in Thailand" to their offering.
Amgen (Nasdaq: AMGN) announced that a pivotal, Phase 3, head-to-head trial evaluating denosumab versus Zometa® (zoledronic acid) in the treatment of bone metastases in 1,901 men with advanced prostate cancer met its primary and secondary endpoints. Denosumab demonstrated superiority over Zometa for both delaying the time to the first on-study skeletal related event (SRE) (fracture, radiation to ...
CAMBRIDGE, Mass.----Biogen Idec Inc. , a global biotechnology leader in the discovery, development, manufacturing, and commercialization of innovative therapies, today announced its full year and fourth quarter 2009 results.
Q: I recently read in one of your newsletters about fibromyalgia. I have polymyalgia. Could you please explain the difference between the two and what medication I should be using? I would appreciate hearing from you. A: Fibromyalgia is a disorder chara
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |